The Aortic Watershed Phenomenon and Differential Hypoxemia During Peripheral Venoarterial ECMO: A Scoping Review of Clinical and Experimental Evidence
5 affiliations
- 1Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada
- 2Case Western Reserve University, Cleveland, OH 44106, USA
- 3Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada
- 4Division of Cardiac Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA
- 5Department of Thoracic and Cardiovascular Surgery, Georg-August-University Goettingen, 37075 Goettingen, Germany
Abstract
Extracorporeal membrane oxygenation (ECMO) is a widely used technology in cardiac surgery practice. A clinically significant yet underexplored presentation that occurs during peripheral femoro-femoral venoarterial ECMO (VA-ECMO) is differential hypoxemia (DH) or Harlequin syndrome. This phenomenon may occur when the aortic mixing interface shifts distally, and the coronary and supra-aortic circulations receive predominantly hypoxemic native blood. DH may reduce cerebral and myocardial oxygen delivery and produce clinically meaningful arterial partial pressure of carbon dioxide (PaCO2) gradients. This scoping review aimed to synthesize clinical and experimental evidence on the mechanisms, detection, management, and outcomes of DH during peripheral VA-ECMO. A scoping review of the watershed phenomenon during peripheral VA-ECMO was conducted using MEDLINE and EMBASE in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The initial search identified 245 records. After screening, 16 studies were included. DH frequency ranged from 1.5% to 13.3%, but estimates varied substantially across case definitions, diagnostic thresholds, and cohort compositions. Regarding management, configuration-targeted strategies improved surrogates of upper-body oxygenation and perfusion, which included shifting venous drainage toward the superior vena cava/upper right atrium, in turn converting to veno-arteriovenous ECMO with internal jugular return (with flow-splitting control) and relocating arterial return to more proximal/antegrade sites. Detection extended beyond paired upper- and lower-body oximetry/arterial blood gases; reported approaches included contrast-enhanced ultrasound, Doppler mapping, and positional computed tomography angiography (CTA). Experimental models described why DH may persist despite higher ECMO flow as native output increases, and they highlight anatomy- and cannulation-dependent cerebral and coronary vulnerability. DH appears to be a predictable, physiology-driven complication best mitigated by modifying drainage position and/or circuit configuration rather than increasing ECMO flow. To further explore this phenomenon, adopting standardized definitions, investigating bedside localization tools, and conducting prospective comparative studies could be considered.
Related
- Successful Implementation of Peripheral Venoarterial ECMO in a Patient With Eisenmenger Syndrome as a Bridge to Lung Transplant: A Case Report
- Head-to-head comparison of central and peripheral venoarterial ECMO in normal ovine hearts and in cardiogenic shock
- Comparative Effectiveness of Differential Target Multiplexed Spinal Cord Stimulation and Traditional Spinal Cord Stimulation with or without Subcutaneous Peripheral Nerve Field Stimulation for Chronic Back and Leg Pain
- Behavioral-metabolic phenotypes and differential risks of diabetic kidney disease and peripheral neuropathy in type 2 diabetes: a latent class analysis
- Effects of a quick response code–based caregiver video education program on peripheral intravenous catheter maintenance–related outcomes in hospitalized children in South Korea: a single-center quasi-experimental study
BibTeX
@article{hasheminia2026aortic,
title = {{The Aortic Watershed Phenomenon and Differential Hypoxemia During Peripheral Venoarterial ECMO: A Scoping Review of Clinical and Experimental Evidence}},
author = {Amin Hasheminia and Seif Kotb and Adham Elsherbini and Léonie Girard and Yasir Abu-Omar and Yakov Elgudin and Aron Frederik Popov and Mohammad El Diasty},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
month = sep,
doi = {10.31083/rcm52934},
url = {https://doi.org/10.31083/rcm52934},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Aortic Watershed Phenomenon and Differential Hypoxemia During Peripheral Venoarterial ECMO: A Scoping Review of Clinical and Experimental Evidence
AU - Amin Hasheminia
AU - Seif Kotb
AU - Adham Elsherbini
AU - Léonie Girard
AU - Yasir Abu-Omar
AU - Yakov Elgudin
AU - Aron Frederik Popov
AU - Mohammad El Diasty
PY - 2026
DA - 2026/09/30
JO - Reviews in Cardiovascular Medicine
DO - 10.31083/rcm52934
UR - https://doi.org/10.31083/rcm52934
AB - Extracorporeal membrane oxygenation (ECMO) is a widely used technology in cardiac surgery practice. A clinically significant yet underexplored presentation that occurs during peripheral femoro-femoral venoarterial ECMO (VA-ECMO) is differential hypoxemia (DH) or Harlequin syndrome. This phenomenon may occur when the aortic mixing interface shifts distally, and the coronary and supra-aortic circulations receive predominantly hypoxemic native blood. DH may reduce cerebral and myocardial oxygen delivery and produce clinically meaningful arterial partial pressure of carbon dioxide (PaCO2) gradients. This scoping review aimed to synthesize clinical and experimental evidence on the mechanisms, detection, management, and outcomes of DH during peripheral VA-ECMO. A scoping review of the watershed phenomenon during peripheral VA-ECMO was conducted using MEDLINE and EMBASE in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The initial search identified 245 records. After screening, 16 studies were included. DH frequency ranged from 1.5% to 13.3%, but estimates varied substantially across case definitions, diagnostic thresholds, and cohort compositions. Regarding management, configuration-targeted strategies improved surrogates of upper-body oxygenation and perfusion, which included shifting venous drainage toward the superior vena cava/upper right atrium, in turn converting to veno-arteriovenous ECMO with internal jugular return (with flow-splitting control) and relocating arterial return to more proximal/antegrade sites. Detection extended beyond paired upper- and lower-body oximetry/arterial blood gases; reported approaches included contrast-enhanced ultrasound, Doppler mapping, and positional computed tomography angiography (CTA). Experimental models described why DH may persist despite higher ECMO flow as native output increases, and they highlight anatomy- and cannulation-dependent cerebral and coronary vulnerability. DH appears to be a predictable, physiology-driven complication best mitigated by modifying drainage position and/or circuit configuration rather than increasing ECMO flow. To further explore this phenomenon, adopting standardized definitions, investigating bedside localization tools, and conducting prospective comparative studies could be considered.
SN - 1530-6550
SN - 2153-8174
ER -